Medpace Holdings Operating Expenses 2014-2023 | MEDP

Medpace Holdings annual/quarterly operating expenses history and growth rate from 2014 to 2023. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  • Medpace Holdings operating expenses for the quarter ending December 31, 2023 were $0.411B, a 29.41% increase year-over-year.
  • Medpace Holdings operating expenses for the twelve months ending December 31, 2023 were $1.549B, a 31.13% increase year-over-year.
  • Medpace Holdings annual operating expenses for 2023 were $1.549B, a 31.13% increase from 2022.
  • Medpace Holdings annual operating expenses for 2022 were $1.181B, a 25.17% increase from 2021.
  • Medpace Holdings annual operating expenses for 2021 were $0.944B, a 24.36% increase from 2020.
Medpace Holdings Annual Operating Expenses
(Millions of US $)
2023 $1,549
2022 $1,181
2021 $944
2020 $759
2019 $734
2018 $604
2017 $371
2016 $369
2015 $338
2014 $322
2013 $214
Medpace Holdings Quarterly Operating Expenses
(Millions of US $)
2023-12-31 $411
2023-09-30 $408
2023-06-30 $382
2023-03-31 $348
2022-12-31 $318
2022-09-30 $306
2022-06-30 $291
2022-03-31 $267
2021-12-31 $254
2021-09-30 $242
2021-06-30 $236
2021-03-31 $212
2020-12-31 $205
2020-09-30 $184
2020-06-30 $175
2020-03-31 $195
2019-12-31 $194
2019-09-30 $186
2019-06-30 $179
2019-03-31 $175
2018-12-31 $161
2018-09-30 $152
2018-06-30 $147
2018-03-31 $143
2017-12-31 $97
2017-09-30 $93
2017-06-30 $90
2017-03-31 $91
2016-12-31 $95
2016-09-30 $95
2016-06-30 $92
2016-03-31 $87
2015-12-31
2015-09-30 $85
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $12.267B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $124.869B 15.67
Cencora (COR) United States $48.051B 19.18
ICON (ICLR) Ireland $25.434B 24.01
DiDi Global (DIDIY) China $24.400B 0.00
Avantor (AVTR) United States $16.238B 23.94
Viatris (VTRS) United States $13.880B 3.96
CochLear (CHEOY) $13.776B 0.00
Revvity (RVTY) United States $12.539B 21.83
Charles River Laboratories (CRL) United States $11.798B 21.50
EUROFINS SCIENT (ERFSF) Luxembourg $11.548B 0.00
Natera (NTRA) United States $11.205B 0.00
Solventum (SOLV) United States $11.115B 0.00
Sonic Healthcare (SKHHY) Australia $8.282B 0.00
Amplifon S.p.A (AMFPF) Italy $7.290B 37.01
HealthEquity (HQY) United States $6.886B 51.45
Bausch + Lomb (BLCO) Canada $5.197B 19.99
Organon (OGN) United States $4.771B 4.59
Doximity (DOCS) United States $4.444B 33.08
PACS (PACS) United States $3.713B 0.00
Sotera Health (SHC) United States $3.227B 15.83
Surgery Partners (SGRY) United States $3.120B 28.88
Progyny (PGNY) United States $3.079B 51.68
GoodRx Holdings (GDRX) United States $2.840B 143.80
Life Times (LTH) United States $2.783B 30.76
Premier (PINC) United States $2.511B 9.19
Teladoc Health (TDOC) United States $2.203B 0.00
AMN Healthcare Services Inc (AMN) United States $2.164B 7.00
Agilon Health (AGL) United States $2.055B 0.00
BrightSpring Health Services (BTSG) United States $1.811B 0.00
Agiliti (AGTI) United States $1.368B 22.33
NovoCure (NVCR) Jersey $1.360B 0.00
Establishment Labs Holdings (ESTA) $1.331B 0.00
Alignment Healthcare (ALHC) United States $0.985B 0.00
Pediatrix Medical (MD) United States $0.760B 7.86
Embecta (EMBC) United States $0.594B 3.92
InnovAge Holding (INNV) United States $0.531B 0.00
Auna S.A (AUNA) Luxembourg $0.522B 0.00
Enhabit (EHAB) United States $0.503B 45.59
COMPASS Pathways (CMPS) United Kingdom $0.492B 0.00
LifeMD (LFMD) United States $0.482B 0.00
Sonida Senior Living (SNDA) United States $0.434B 0.00
Beauty Health (SKIN) United States $0.400B 0.00
CareDx (CDNA) United States $0.391B 0.00
DocGo (DCGO) United States $0.376B 60.17
MultiPlan (MPLN) United States $0.371B 0.00
Sera Prognostics (SERA) United States $0.349B 0.00
ModivCare (MODV) United States $0.335B 4.44
Sharecare (SHCR) United States $0.290B 0.00
GeneDx Holdings (WGS) United States $0.289B 0.00
Ascend Wellness Holdings (AAWH) United States $0.269B 0.00
Biodesix (BDSX) United States $0.142B 0.00
So-Young (SY) China $0.125B 41.83
Oncology Institute (TOI) United States $0.085B 0.00
Pono Capital Two (PTWO) United States $0.078B 0.00
IceCure Medical (ICCM) Israel $0.055B 0.00
NeueHealth (NEUE) United States $0.050B 0.00
Co-Diagnostics (CODX) United States $0.035B 0.00
SeaStar Medical Holding (ICU) United States $0.033B 0.00
Nutex Health (NUTX) United States $0.033B 0.00
Singular Genomics Systems (OMIC) United States $0.030B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
DermTech (DMTK) United States $0.021B 0.00
OncoCyte (OCX) United States $0.021B 0.00
BIMI Holdings (BIMI) United States $0.014B 0.00
Aesthetic Medical Hldngs Group (AIH) China $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
TRxADE HEALTH (MEDS) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
XWELL (XWEL) United States $0.008B 0.00
NewGenIvf Group (NIVF) Singapore $0.007B 0.00
OpGen (OPGN) United States $0.007B 0.00
Assure Holdings (IONM) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00